Skip to main content
MEDTECS INTERNATIONAL CORP LTD logo

MEDTECS INTERNATIONAL CORP LTD — Investor Relations & Filings

Ticker · 546 ISIN · BMG5958R1043 SGX Manufacturing
Open in API
Filings indexed 31 across all filing types
Latest filing 2025-09-24 Regulatory Filings
Country SG Singapore
Listing SGX 546

About MEDTECS INTERNATIONAL CORP LTD

https://www.medtecs.com/

Medtecs International Corporation Limited is a global provider of healthcare products and services, specializing as a leading supplier and total solution provider of personal protective equipment (PPE). The company's core activities include the manufacturing, trading, and distribution of a comprehensive range of PPE, medical uniforms and apparel, and consumer health products. Additionally, Medtecs offers logistics services and integrated hospital services. It serves healthcare institutions, manufacturing industries, and general consumers across the United States, Europe, and Asia Pacific. With diversified manufacturing facilities located throughout Asia, Medtecs ensures stable production capacity and adheres to rigorous international standards and certifications, providing reliable and effective protective solutions.

Recent filings

Filing Released Lang Actions
General Announcement::Monthly update pursuant to Catalist Rule 704(22)
Regulatory Filings Classification · 95% confidence The document is titled as a 'Monthly Update Pursuant to Catalist Rule 704(22)' and provides an update on the winding-up application and court order related to Resilient Medical. It references previous announcements and states that further updates will be provided as material developments occur. The document is relatively short (3689 characters) and serves as a regulatory update rather than a full financial report or detailed analysis. It does not contain financial statements or substantive financial data, nor is it a certification or officer attestation. It is an ongoing regulatory announcement to shareholders about legal and corporate developments, fitting the description of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-09-24 English
Change - Change of Catalist Sponsor::CHANGE OF CONTINUING SPONSOR
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the company's continuing sponsor, which is a corporate governance or regulatory compliance matter. It does not contain financial statements, earnings data, or detailed management discussion. The document is relatively short (2232 characters) and focuses on the appointment of a new continuing sponsor and confirmation of compliance with listing rules. This fits best under a regulatory announcement category related to board or management changes or compliance updates. However, since it is specifically about a change in continuing sponsor (a regulatory/compliance role) and not about board members or senior management changes, it does not fit the MANG category. It is also not a report or financial filing. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-09-05 English
General Announcement::CHANGE OF COMPANY SECRETARY
Board/Management Information Classification · 100% confidence The document announces the appointment of a new Company Secretary and the departure of the previous one. It is a formal announcement related to changes in the company's board or senior management personnel. The document is short (1511 characters) and does not contain financial data, audit information, or report content. It is not a report or financial filing but a management change announcement. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-09-01 English
General Announcement::Monthly update pursuant to Catalist Rule 704(22)
Regulatory Filings Classification · 95% confidence The document is titled as a 'Monthly Update Pursuant to Catalist Rule 704(22)' and provides an update on the winding-up application and court order related to Resilient Medical. It references previous announcements and states that further updates will be provided as material developments occur. The document is relatively short (3773 characters) and serves as a regulatory update rather than a full financial report or detailed analysis. It does not contain financial statements or detailed financial data, nor is it a certification or officer attestation. The content aligns with a regulatory announcement updating shareholders on ongoing legal and corporate developments, consistent with Regulatory Filings (RNS).
2025-08-25 English
Financial Statements and Related Announcement::Half Yearly Results
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Half Year Financial Statements For The Period Ended 30 June 2025' and contains detailed financial statements including income statements, balance sheets, cash flow statements, and changes in equity. It includes notes to the condensed interim financial statements and explanatory notes relevant to understanding the financial data. The presence of half-year period data and comprehensive financial information indicates this is an interim financial report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-13 English
General Announcement::Monthly update pursuant to Catalist Rule 704(22)
Regulatory Filings Classification · 95% confidence The document is a monthly update pursuant to Catalist Rule 704(22) regarding the liquidation proceedings of a subsidiary (Resilient Medical). It provides information about the creditors' meeting, the liquidation process, and the financial impact assessment related to the winding-up. The document is an announcement updating shareholders on ongoing legal and financial developments rather than a full financial report or detailed management discussion. It does not contain comprehensive financial statements or detailed analysis typical of interim or annual reports. It is also not a certification or a proxy statement. Given the nature of the content—an update on liquidation proceedings and related financial impact without full financial data—it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance updates that do not fit other specific categories.
2025-07-25 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.